[ad_1]
Supreme Court today raised concerns over alleged unethical marketing practices by pharmaceutical companies that leads to prescription of high-cost or over-priced brands by healthcare professionals. The Supreme Court bench of Justice DY Chandrachud and Justice AS Bopanna was informed that makers of popular anti-fever drug Dolo-650 mg tablet had invested Rs 1,000 crore in freebies to have its medicine prescribed to patients.
[ad_2]
Source link